Evaluation of serum CXCL16 as an inflammatory marker in chronic kidney disease
Abstract
Background: Particularly vulnerable are patients who suffer from diabetes, hypertension, and renal failure, as these conditions increase the likelihood of serious complications and even death. There is evidence from previous studies that CXCL16 plays a role in renal disease.Aim: To examine CXCL16 serum levels in chronic renal disease patients in order to identify inflammatory markers.Subjects and methods: Sixty patients with chronic renal illness and thirty healthy volunteers served as the subjects of this prospective, comparative study that ran from April 2024 to April 2025 at the Clinical Pathology Department at Al-Azhar University Hospitals in Cairo, Egypt.Results: There was a substantial difference in serum CXCL16 levels between the case and control groups (p
Fields of Study & Subjects
Chronic Kidney Disease and Diabetes
Dialysis and Renal Disease Management
Acute Kidney Injury Research
Publication details
- Journal / source
- Al-Azhar International Medical Journal /Al-Azhar International Medical Journal
- Volume
- 0
- Issue
- 0
- Pages
- 165–170
- Publication date
- 27 January 2026
- Language
- EN